Google Scholar | Citations: 16429| h-index: 32 | i10-index: 482
Pre-eclampsia and maternal mortality: relationship between risk factors, early diagnosis and prevention
Imagem licenciada por Canva.com
PDF (Portuguese (Brazil))

Supplementary Files

Certificado (Portuguese (Brazil))

Keywords

Gestational hypertension
Preeclampsia
Maternal death
HELLP syndrome

How to Cite

Pre-eclampsia and maternal mortality: relationship between risk factors, early diagnosis and prevention. (2022). Electronic Journal Collection Health, 15(7), e10533. https://doi.org/10.25248/reas.e10533.2022

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: To discuss hypertensive diseases during pregnancy and discuss their risk factors, diagnosis and prevention.  Bibliographic review: Maternal death is characterized by death from complications generated or aggravated by pregnancy during the period that includes pregnancy, childbirth and puerperium.  Among the causes of these complications, gestational hypertension is among the main ones, even though it is potentially preventable.  Studies show a significant association of low socioeconomic status, maternal age, early gestational age and previous chronic diseases with unfavorable maternal outcomes. Although, there are no well-defined protective measures, research indicates that prevention can be provided by the use of aspirin, calcium supplementation and continuous monitoring of pregnancy. When not avoided, hypertensive disorders require an early diagnosis, which can be done through specific tests, such as the measurement of metalloprotease ADAM12-S, and allows obstetric interventions to be taken to avoid severe maternal conditions.  Ideally, these interventions should be taken in the context of an empowered health system, which is often not guaranteed. Final considerations: It was found that there are multiple indicators to establish risk factors, early diagnosis and prevention.  However, further studies should be encouraged aiming at the creation of consolidated protocols in the management of hypertensive pregnant women.

PDF (Portuguese (Brazil))

References

AGOSTINIS C, et al. COVID-19, Pre-eclampsia and Complement System. Frontiers in Immunology, 2021; 12: 4744.

ASSIS TR, et al. Estudo dos Principais Fatores de Risco Maternos nas Síndromes Hipertensivas da Gestação. Arquivos Brasileiros de Cardiologia, 2008; 91(1): 11-17.

BHERING N, et al. A Síndrome Semelhante a Pré-eclâmpsia induzida pela COVID-19: Uma Revisão da Literatura. Brazilian Journal of Health Review, 2021; 4(2): 4493-4507.

BRITO K, et al. The prevalence of hypertensive syndromes particular pregnancy (GHS). Revista de pesquisa Cuidado é Fundamental Online, 2015; 7(3).

COSTA ES, et al. As principais causas de morte maternas entre mulheres no Brasil. Revista Eletrônica Acervo Saúde, 2021; 13 (1): 5826-5826.

EL-SHERBINY W, et al. Metalloprotease (ADAM12-S) as a predictor of preeclampsia: correlation with severity, maternal complications, fetal outcome, and Doppler parameters. Hypertension in Pregnancy, 2012; 31(4): 442-450.

FEDERAÇÃO INTERNACIONAL DE GINECOLOGIA E OBSTETRÍCIA (FIGO). THE INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention. 2019; 145(1): 1-33. Disponível em: https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/ijgo.12802. Acesso em: 27 de Julho de 2021.

GIORDANO JC, et al. The burden of eclampsia: results from a multicenter study on surveillance of severe maternal morbidity in Brazil. PLoS One. 2014; 9(5).

GOTTARDI E, et al. Preeclampsia before 26 weeks of gestation: Obstetrical prognosis for the subsequent pregnancy. J Gynecol Obstet Hum Reprod, 2021; 50(3).

HOFMEYR G, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev, 2018; 10.

JING Y, et al. Potential Influence of COVID-19/ACE2 on the Female Reproductive System. Molecular Human Reproduction, 2020; 26(6): 367-373.

KAHHALE S, et al. Pré-eclâmpsia. Revista De Medicina, 2018; 97(2): 226-234.

KATSURAGI S, et al. Analysis of preventability of hypertensive disorder in pregnancy-related maternal death using the nationwide registration system of maternal deaths in Japan. Journal of maternal-fetal & neonatal medicine, 2019, 32(20): 3420-3426.

LECARPENTIER E, HADDAD B. Aspirin for the prevention of placenta-mediated complications in pregnant women with chronic hypertension. Journal of gynecology obstetrics and human reproduction, 2020, 49(9).

MAGED AM, et al. Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management. J Matern Fetal Neonatal Med, 2020; 33(2): 314-321.

MAHRAN A, et al. Risck factors and outcome of patients with eclampsia at a tertiary hospital in Egypt. BMC Pregnancy and Childbirth, 2017, 17(1): 1-7.

MINISTÉRIO DA SAÚDE. Secretaria de Atenção Primária à Saúde, Departamento de Ações Programáticas. Manual de gestação de alto risco. Brasília – DF: Brasil, 2022. Disponível em: https://portaldeboaspraticas.iff.fiocruz.br/wp-content/uploads/2022/03/manual_gestacao_alto_risco.pdf. Acesso em 04 abr. 2022.

MARTINS ACS, SILVA LS. Perfil epidemiológico de mortalidade materna. Revista Brasileira de Enfermagem, 2018; 71: 677-683.

NETO HNM, et al. Fatores relacionados à ocorrência da hipertensão no período gestacional: uma revisão integrativa. Revista Ciência & Saberes-UniFacema, 2019; 4(3).

REZENDE GP, et al. Maternal and Perinatal Outcomes of Pregnancies Complicated by Chronic Hypertension Followed at a Referral Hospital. Revista Brasileira de Ginecologia e Obstetrícia, 2020; 42: 248-254.

RODRIGUES ARM, CAVALCANTE AES, VIANA AB. Mortalidade materna no Brasil entre 2006-2017: análise temporal. ReTEP, 2019; 11(1): 3-9.

SANTOS FPA, et al. A produção do cuidado a usuários com hipertensão arterial e as tecnologias em saúde. Revista da Escola de Enfermagem da USP, 2013; 47(1): 107-114.

SOCIEDADE BRASILEIRA DE CARDIOLOGIA (SBC). Diretriz da Sociedade Brasileira de Cardiologia para Gravidez na Mulher Portadora de Cardiopatia. 2009. Disponível em: https://www.scielo.br/pdf/abc/v93n6s1/v93n6s1a17.pdf. Acesso em: 27 de Julho de 2021.

WALID SE, et al. Endothelial nitric oxide synthase (eNOS) (Glu298Asp) and urotensin II (UTS2 S89N) gene polymorphisms in preeclampsia: prediction and correlation with severity in Egyptian females. Hypertension in Pregnancy, 2013; 32(3): 292-303.

ZANETTE E, et al. Maternal near miss and death among women with severe hypertensive disorders: a Brazilian multicenter surveillance study. Reprod Health, 2014; 11(1): 1-11.